EFFIPURE
DEAD

Serial Number

78246735

Owner

Exact Sciences Corporation

Attorney

Douglas R. Wolf

Filing Date

May 7, 2003

Add to watchlist:

No watchlists yet
View on USPTO

EFFIPURE Trademark

Serial Number: 78246735

EFFIPURE is a trademark filed by Exact Sciences Corporation on May 7, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Exact Sciences Corporation (126 trademarks)

441 Charmany Drive
Madison, WI 53719

Entity Type: 03

Trademark Details

Filing Date

May 7, 2003

Registration Date

Not Registered

Published for Opposition

July 20, 2004

Goods & Services

Reagents for clinical medical use; Reagents for clinical medical use in binding assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in binding assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in binding assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in electrophoresis assays, namely assays to detect contamination in food products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in blood products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect biological contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect biological contamination in food products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect contamination in blood products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect pathogenic contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect food contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect blood contamination; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect viral contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to identify bacterial pathogens in platelet products; Reagent kits comprised of reagents for clinical medical use; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect analytes; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify analytes; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate analytes; Reagent kits comprised of reagents for clinical medical use, namely assays to detect nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect viral contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in platelet products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in platelet products; and Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to identify bacterial pathogens

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 13, 2005 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 13, 2005 ABN6
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2005 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2005 REAP
SOU EXTENSION 1 GRANTED
Apr 5, 2005 EX1G
SOU EXTENSION 1 FILED
Mar 30, 2005 EXT1
FAX RECEIVED
Mar 30, 2005 FAXX
NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 12, 2004 NOAM
PUBLISHED FOR OPPOSITION
Jul 20, 2004 PUBO
NOTICE OF PUBLICATION
Jun 30, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2004 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2004 CRFA
PAPER RECEIVED
Apr 2, 2004 MAIL
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Nov 17, 2003 UNPR
PAPER RECEIVED
Nov 17, 2003 MAIL
NON-FINAL ACTION MAILED
Oct 15, 2003 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2003 DOCK
PAPER RECEIVED
Aug 6, 2003 MAIL